| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Septerna, Inc.
13G/A
Amendment 2
SEPN · 81734D104
|
13.0% |
11/16/2026
Event 9/30/2026
|
|||
| Third Rock Ventures V, L.P. | 13.0% | ||||
| Third Rock Ventures GP V, L.P. | 13.0% | ||||
| TRV GP V, LLC | 13.0% | ||||
| Third Rock Ventures VI, L.P. | 9.0% | ||||
| Third Rock Ventures GP VI, L.P. | 9.0% | ||||
| TRV GP VI, LLC | 9.0% | ||||
|
Rapport Therapeutics, Inc.
13G/A
Amendment 1
RAPP · 75383L102
|
13.1% |
8/14/2026
Event 6/30/2026
|
|||
| Third Rock Ventures V, L.P. | 13.1% | ||||
| Third Rock Ventures GP V, L.P. | 13.1% | ||||
| TRV GP V, LLC | 13.1% | ||||
| Third Rock Ventures VI, L.P. | 2.0% | ||||
| Third Rock Ventures GP VI, L.P. | 2.0% | ||||
| TRV GP VI, LLC | 2.0% | ||||
|
Septerna, Inc.
13G/A
Amendment 1
SEPN · 81734D104
|
14.0% |
5/9/2025
Event 3/31/2025
|
|||
| Third Rock Ventures V, L.P. | 14.0% | ||||
| Third Rock Ventures GP V, L.P. | 14.0% | ||||
| TRV GP V, LLC | 14.0% | ||||
| Third Rock Ventures VI, L.P. | 9.5% | ||||
| Third Rock Ventures GP VI, L.P. | 9.5% | ||||
| TRV GP VI, LLC | 9.5% | ||||
|
Rapport Therapeutics, Inc.
13G
RAPP · 75383L102
|
19.5% |
2/13/2025
Event 12/31/2024
|
|||
| Third Rock Ventures V, L.P. | 19.5% | ||||
| Third Rock Ventures GP V, L.P. | 19.5% | ||||
| TRV GP V, LLC | 19.5% | ||||
| Third Rock Ventures VI, L.P. | 2.7% | ||||
| Third Rock Ventures GP VI, L.P. | 2.7% | ||||
| TRV GP VI, LLC | 2.7% | ||||
|
Septerna, Inc.
13G
SEPN · 81734D104
|
14.0% |
2/13/2025
Event 12/31/2024
|
|||
| Third Rock Ventures V, L.P. | 14.0% | ||||
| Third Rock Ventures GP V, L.P. | 14.0% | ||||
| TRV GP V, LLC | 14.0% | ||||
| Third Rock Ventures VI, L.P. | 7.1% | ||||
| Third Rock Ventures GP VI, L.P. | 7.1% | ||||
| TRV GP VI, LLC | 7.1% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.